TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
33
Total Principal
231M
Shares change
+12.3M
Total reported value, excl. options
$197M
Value change
+$10.8M
Put/Call ratio
0
Number of buys
10
Number of sells
-9
Price
$0.85
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.